The TAT-JIP peptide and Notch 1-IC (Notch intracellular domain) can be used for ameliorating autoimmune inflammatory diseases and glomerulosclerosis, respectively, through a competitive inhibition of the interaction of JIP1 and JNK1/2/3. The gene discussed is MAPK8; the disease is glomerulosclerosis.